BASi is a drug development services firm providing contract preclinical toxicology, pharmaceutical analysis and bioanalytical services (large and small molecule determinations plus method development) as well as specialized instrumentation for in vivo sampling and electrochemical detection for LC.
General toxicology, carcinogenicity studies, behavioral toxicology, immunotoxicology and biomarkers, clinical chemistry and pathology panels, necropsy and histology with special stains, pharmacokinetics and drug metabolism.
High sample throughput is made possible by a total of 37 LC-MS/MS instruments and the latest in related technology, such as LDTD (Laser Diode Thermal Desorption), which increases analytical capacity and accelerates turn-around. Method development and validation, clinical trial sample analysis, early discovery bioanalysis.
Large Molecule Bioanalysis
Macromolecule PK/TK, immunogenicity assays, biomarker services, EIA- or ELISA-based applications, enzyme kinetic assays, method development.
Method development and validation, NDA IND and QC stability testing and program support, final product release testing, comparator product testing, forced degradation studies, dosing solution analysis, compendial testing, formulation development support, stability storage on site.
Since 1974, BASi has led the industry as an innovator in the design and manufacture of specialized instrumentation and accessories for electrochemistry and in vivo sampling.